Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease
Adult
Male
Kidney Function Tests
Article
Cohort Studies
Machine Learning
Young Adult
03 medical and health sciences
0302 clinical medicine
Predictive Value of Tests
Risk Factors
Electronic Health Records
Humans
Diabetic Nephropathies
Aged
Aged, 80 and over
Middle Aged
Prognosis
United States
3. Good health
Disease Progression
Female
Biomarkers
Glomerular Filtration Rate
DOI:
10.1007/s00125-021-05444-0
Publication Date:
2021-04-02T11:02:52Z
AUTHORS (13)
ABSTRACT
Abstract Aim Predicting progression in diabetic kidney disease (DKD) is critical to improving outcomes. We sought develop/validate a machine-learned, prognostic risk score (KidneyIntelX™) combining electronic health records (EHR) and biomarkers. Methods This an observational cohort study of patients with prevalent DKD/banked plasma from two EHR-linked biobanks. A random forest model was trained, performance (AUC, positive negative predictive values [PPV/NPV], net reclassification index [NRI]) compared that clinical Kidney Disease: Improving Global Outcomes (KDIGO) categories for predicting composite outcome eGFR decline ≥5 ml/min per year, ≥40% sustained decline, or failure within 5 years. Results In 1146 patients, the median age 63 years, 51% were female, baseline 54 ml min −1 [1.73 m] −2 , urine albumin creatinine ratio (uACR) 6.9 mg/mmol, follow-up 4.3 years 21% had endpoint. On cross-validation derivation ( n = 686), KidneyIntelX AUC 0.77 (95% CI 0.74, 0.79). validation 460), 0.76, By comparison, 0.62 0.61, 0.63) 0.61 0.60, validation. Using cut-offs, stratified 46%, 37% 17% into low-, intermediate- high-risk groups endpoint, respectively. The PPV progressive function group 61% vs 40% highest strata by KDIGO categorisation p < 0.001). Only 10% those scored as low experienced (i.e., NPV 90%). NRI event 41% 0.05). Conclusions improved prediction outcomes over models individuals early stages DKD. Graphical abstract
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (45)
CITATIONS (106)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....